Drug Type Small molecule drug |
Synonyms- |
Target |
Action positive allosteric modulator |
Mechanism CHRNA7 positive allosteric modulator(Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | United Arab Emirates | 20 Oct 2025 | |
| Inflammation | Preclinical | United Arab Emirates | 20 Oct 2025 | |
| Neurodegenerative Diseases | Preclinical | United Arab Emirates | 20 Oct 2025 | |
| Neurodegenerative Diseases | Preclinical | United Arab Emirates | 20 Oct 2025 |





